MD1425Y - Metodă de hemostază endoscopică a hemoragiilor variceale cirogene - Google Patents

Metodă de hemostază endoscopică a hemoragiilor variceale cirogene Download PDF

Info

Publication number
MD1425Y
MD1425Y MDS20190107A MDS20190107A MD1425Y MD 1425 Y MD1425 Y MD 1425Y MD S20190107 A MDS20190107 A MD S20190107A MD S20190107 A MDS20190107 A MD S20190107A MD 1425 Y MD1425 Y MD 1425Y
Authority
MD
Moldova
Prior art keywords
hemorrhages
variceal
cirrhotic
endoscopic hemostasis
aprotinin
Prior art date
Application number
MDS20190107A
Other languages
English (en)
Russian (ru)
Inventor
Георге АНГЕЛИЧ
Ион ПАНИЧ
Серджиу ПИСАРЕНКО
Олег КРУДУ
Олег САВИН
Татьяна ЗУГРАВ
Георге ЛУПУ
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDS20190107A priority Critical patent/MD1425Z/ro
Publication of MD1425Y publication Critical patent/MD1425Y/ro
Publication of MD1425Z publication Critical patent/MD1425Z/ro

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la medicină, în special la hemostaza endoscopică a hemoragiilor din varice esofago-gastrice în caz de ciroză hepatică.Esenţa invenţiei constă în injectarea în lumenul varicelor sângerânde a unui adeziv fibrinic, care conţine soluţie de fibrinogen, care se amestecă cu soluţii de aprotinin, trombină şi clorură de Ca+2 în următorul raport al componentelor în 1 ml:unde trombina se dizolvă în 5...20 ml de soluţie de metronidazol cu concentraţia de 5 mg/ml, la care se adaugă soluţiile de aprotinin şi clorură de Ca+2, iar în soluţia de fibrinogen se adaugă 1 ml de colorant Trypan Blue cu concentraţia de 0,6 mg/ml, după care componentele se injectează separat cu polimerizarea definitivă în lumenul varicelui.
MDS20190107A 2019-10-15 2019-10-15 Metodă de hemostază endoscopică a hemoragiilor variceale cirogene MD1425Z (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20190107A MD1425Z (ro) 2019-10-15 2019-10-15 Metodă de hemostază endoscopică a hemoragiilor variceale cirogene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20190107A MD1425Z (ro) 2019-10-15 2019-10-15 Metodă de hemostază endoscopică a hemoragiilor variceale cirogene

Publications (2)

Publication Number Publication Date
MD1425Y true MD1425Y (ro) 2020-03-31
MD1425Z MD1425Z (ro) 2020-12-31

Family

ID=70056181

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20190107A MD1425Z (ro) 2019-10-15 2019-10-15 Metodă de hemostază endoscopică a hemoragiilor variceale cirogene

Country Status (1)

Country Link
MD (1) MD1425Z (ro)

Also Published As

Publication number Publication date
MD1425Z (ro) 2020-12-31

Similar Documents

Publication Publication Date Title
Desai et al. Perioperative patient blood management to improve outcomes
Wada et al. Expert consensus for the treatment of disseminated intravascular coagulation in Japan
Guglietta et al. Hypercoagulation and complement: Connected players in tumor development and metastases
EP2698378A1 (en) Anticoagulant polypeptide and applications thereof
Bijak et al. Popular naturally occurring antioxidants as potential anticoagulant drugs
Ickx et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation
Flight et al. Textilinin‐1, an alternative anti‐bleeding agent to aprotinin: importance of plasmin inhibition in controlling blood loss
CR20200605A (es) Compuestos y métodos para la reducción de la expresión de fxi
Hayashida et al. Cardiac operations in cirrhotic patients
Eeson et al. Hemostasis and hepatic surgery
Assafim et al. Exploiting the antithrombotic effect of the (pro) thrombin inhibitor bothrojaracin
Valla et al. Portal vein thrombosis with ruptured oesophageal varices as presenting manifestation of hereditary protein C deficiency.
MD372Y (ro) Metodă de hemostază endoscopică a ulcerului hemoragic în ciroza hepatică decompensată
Ng et al. New anti-thrombotic agents: emphasis on hemorrhagic complications and their management
Makwana et al. Antifibrinolytics in liver surgery
Godier et al. Treatment of massive bleeding with prothrombin complex concentrate: argument against
Al-Khabori et al. Discriminatory power of the intraoperative cell salvage use in the prediction of platelet and plasma transfusion in patients undergoing cardiac surgery
Tanaka et al. Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro
Groenland et al. Antifibrinolytics in liver transplantation
MD344Y (ro) Metodă de tratament al rectohemoragiilor variceale la bolnavii cu ciroză hepatică
Robbins et al. Use of aprotinin therapy in a patient with factor V Leiden
RU2573382C1 (ru) Средство для внутрикожного отбеливания синяка
Ulmer et al. Comparative study of the effects of terlipressin versus splenectomy on liver regeneration after partial hepatectomy in rats
RU2008152839A (ru) Способ катетерной склерооблитерации магистральных подкожных вен нижних конечностей
Leelanukrom et al. Factors affecting intraoperative blood loss during liver resection

Legal Events

Date Code Title Description
FG9Y Short term patent issued
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)